Description:

ODM derived from http://clinicaltrials.gov/show/NCT00717366

Link:

http://clinicaltrials.gov/show/NCT00717366

Keywords:
Versions (1) ▾
  1. 12/9/13
Uploaded on:

December 9, 2013

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility DRKS00006414 NCT00717366 Anemia

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age 5 Years to 17 Years
children aged 5-17 years with clinically stable chronic renal anemia
hemodialysis for >=8 weeks
intravenous stable maintenance epoetin alfa, epoetin beta or darbepoetin alfa for >= 8 weeks before screening
stable maintenance epoetin alfa, epoetin beta or darbepoetin alfa with no more than one dose change <=25% during the 2 weeks of screening.
Exclusion Criteria
overt gastrointestinal bleeding, or bleeding episode necessitating transfusion within 8 weeks before screening
red blood cell transfusions within 8 weeks before screening
active malignant disease.